<DOC>
	<DOCNO>NCT00466778</DOCNO>
	<brief_summary>This case-controlled study use innovative , non-invasive , FDA approve technology measure autonomic nervous system . Detection unsuspected DPN ANS dysfunction may allow physician re-assess current treatment develop new dietary pharmacological strategy . This also immense public health concern since currently 18 million diabetic United States 220 million worldwide .</brief_summary>
	<brief_title>Autonomic Nervous System Dysfunction Peripheral Neuropathy Cohort Asymptomatic Juvenile Diabetic Patients ( Type I ) : A Case-Controlled Study</brief_title>
	<detailed_description>A consecutive cohort 20 neurologically asymptomatic ( absence numbness , tingle , burn pain foot ) patient Type I practice Dr. Richard Noto ( gatekeeper ) associate asked legal guardian enroll case-controlled study use battery safe , neurological test unlikely painful . A second group 20 subject nondiabetic healthy ( age/sex match ) also enrol undergo battery neurological test . The battery test highly accurate , objective safe . Subjects refer enrolled private practice community pediatrician . A BMI derive subject 's height weight assess Dr. Noto . Subjects felt acceptable inclusion criterion receive consecutive number 1 40 initial follow specific number study .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<criteria>Cooperation subject guardian require 60120 minute evaluation . Capable understand comply study protocol . Twenty ( 20 ) male/females juvenile diabetes [ least 3 year duration longer 7 ] ( Type I ) neurologically asymptomatic without numbness , tingle , burn pain foot , age 1018 . Fasting blood glucose great 120 mg time initial diagnosis HbA1C great 6.0 time initial diagnosis indicate individual consider diabetic . BMI range acceptability great 5th percentile less 85th percentile . Symptomatic neurological symptom numbness , tingle , burn pain foot either control diabetic subject . On medication produce peripheral neuropathy , i.e . statin ( Lipitor ) , Dilantin , antineoplastic drug . Unable understand inform consent , i.e . mental retardation , psychosis , communicative impairment , language barrier . Morbid obesity maximum BMI great 85th percentile . Underweight status le 5th percentile BMI .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>